BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6977180)

  • 1. Human interleukin 2: production by both TG cells and other T cells.
    Silva AG; Alvarez JM; Bonnard GD; de Landazuri MO
    Scand J Immunol; 1981 Sep; 14(3):315-20. PubMed ID: 6977180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.
    López-Botet M; Fontán G; Garcia Rodriguez MC; de Landázuri MO
    J Immunol; 1982 Feb; 128(2):679-83. PubMed ID: 6976384
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of human null cells isolated from peripheral lymphocytes by a simultaneous double-rosetting procedure.
    Ng AK; Indiveri F; Russo C; Quaranta V; Pellegrino MA; Ferrone S
    Scand J Immunol; 1981 Sep; 14(3):225-31. PubMed ID: 6460312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R
    J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
    Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
    J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
    Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
    Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lymphocytes which inhibit proliferation of human T cells exposed to lymphocyte-derived mitogenic factors.
    Blomgren H
    Int Arch Allergy Appl Immunol; 1979; 59(2):192-8. PubMed ID: 312769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.
    Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ
    J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine production in T gamma lymphoproliferative disorders.
    Rambaldi A; Rossi V; Allavena P; Introna M; Landolfo S; Bassan R; Barbui T; Mantovani A
    Scand J Immunol; 1986 Feb; 23(2):183-8. PubMed ID: 2419965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface receptors and immune activity of purified human circulating mononuclear cells. IV. The demonstration of seven subclasses of T cells in the circulation of the normal individual: the cytotoxic activities of these cells.
    Richter M; Ettin G; Sklar S; Richter M; Hamdy H; Jodouin CA; Kazaniwsky N
    Cell Immunol; 1983 Dec; 82(2):352-69. PubMed ID: 6228301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for antibody-dependent cell-mediated cytotoxicity by T cells bearing receptors for IgG.
    Shen L; Lydyard PM; Penfold P; Roitt IM
    Clin Exp Immunol; 1979 Feb; 35(2):276-85. PubMed ID: 312173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells.
    Moretta L; Pende D; Cozzani R; Merli A; Bagnasco M; Mingari MC
    Eur J Immunol; 1986 Dec; 16(12):1623-5. PubMed ID: 3102249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human autologous rosette-forming cells. IV. Functional role in T-cell activation.
    Nalet V; Fournier C
    Cell Immunol; 1985 Nov; 96(1):137-46. PubMed ID: 3939108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2.
    Mingari MC; Ferrini S; Pende D; Bottino C; Prigione I; Moretta A; Moretta L
    Int J Cancer; 1987 Oct; 40(4):495-8. PubMed ID: 3117711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction.
    Alcocer-Varela J; Alarcon-Segovia D; Abud-Mendoza C
    Clin Exp Immunol; 1985 Apr; 60(1):31-8. PubMed ID: 3159524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies.
    Fishbein E; Alcocer-Varela J; Alarcón-Segovia D
    Immunology; 1983 Oct; 50(2):223-7. PubMed ID: 6604692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.